Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2020 - 06/30/2020

Lobbyist name	Geoffrey A Gallo
Business name	AstraZeneca Pharmaceuticals, LP
Address	3 Merles Lane
City, state, zip code	Stratham, NH 03885
Country	USA
Agent type	Both
Phone	603-770-9000

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: AstraZeneca Pharmaceuticals LP

Total amount paid by client; lobbyist is unable to report compensation at activity level: $12,000.00

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1853	An Act relative to fail first and patient safety	Support	$0.00	N/A
House Bill	1178	An Act relative to promoting transparency in the pharmaceutical industry	Oppose	$0.00	N/A
Senate Docket	1481	An Act to promote transparency and cost control of pharmaceutical drug prices.	Oppose	$0.00	N/A
House Bill	3551	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
House Bill	1194	An Act establishing Medicare for all in Massachusetts	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Participate in public meetings/discussions pertaining to drug costs (net and gross), value-based contracts with MassHealth, health plans and the HPC, potential drug company testimony at the annual HPC Cost Trends Hearings.	Support	$0.00	N/A
House Bill	4638	An Act providing for diabetes management in schools	Support	$0.00	N/A
House Bill	3481	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
House Bill	1162	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
House Bill	1972	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$0.00	N/A
Senate Bill	552	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
Senate Bill	683	An Act establishing medicare for all in Massachusetts	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.	Support	$0.00	N/A
House Bill	4641	An Act relative to the availability of prescription medication during an emergency	Support	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Support	$0.00	N/A
House Docket	3442	An Act to ensure prescription drug cost transparency and affordability.	Oppose	$0.00	N/A
Senate Bill	715	An Act relative to pharmaceutical price transparency and cost sharing	Oppose	$0.00	N/A
Senate Bill	706	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
House Bill	966	An Act to promote value-based insurance design in the Commonwealth	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Planning and executing executive & legislative tours at our corporate research & development laboratory/campus in the Commonwealth of MA in Waltham.	Neutral	$0.00	N/A
House Bill	4638	An Act providing for diabetes management in schools	Support	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Support	$0.00	N/A
House Bill	629	An Act relative to pharmaceutical pricing	Oppose	$0.00	N/A
Senate Docket	1767	An Act to promote prescription drug prices.	Oppose	$0.00	N/A
Senate Bill	703	An Act to define modest meals and refreshments in prescriber education settings	Oppose	$0.00	N/A
House Bill	931	An Act promoting high value and high quality care	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Discussions with the HPC and/or Advisory Council and CHIA with a focus on health care price variation, gross and net prescription drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO's). My interactions are with HPC Board Members (Commissioners), HPC Staff to include Executive Director, and the staff from the Center of Health Information Analysis (CHIA).	Neutral	$0.00	N/A
Executive	Other	Engaged in the opposition of the Governor's Health Care Bill entitled An Act to Improve Health care by investing in VALUE specifically the provisions under the section of Managing High Drug costs.	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Support	$0.00	N/A
House Bill	1154	An Act to reduce drug costs through transparency	Oppose	$0.00	N/A
House Bill	949	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$0.00	N/A
Senate Bill	695	An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00. Direct involvement with the State's Health Policy Commission (HPC) as a formal member of the Health Policy Commission's (HPC) Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224).	Neutral	$0.00	N/A
House Bill	916	An Act relative to co-pay assistance	Support	$0.00	N/A
House Bill	3581	An Act relative to excise tax on motor vehicles	Oppose	$0.00	N/A
House Docket	2145	AN Act relative to prescription drug price transparency.	Oppose	$0.00	N/A
House Bill	629	An Act relative to pharmaceutical pricing	Oppose	$0.00	N/A
Senate Bill	1304	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Oppose	$0.00	N/A
House Bill	1933	An Act to improve patient access to cancer clinical trial programs	Neutral	$0.00	N/A
Senate Bill	2397	An Act Relative to Pharmaceutical Access, Cost and Transparency.	Support	$0.00	N/A
Senate Bill	614	An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications	Support	$0.00	N/A
House Docket	3067	An Act to reduce drug costs through transparency.	Oppose	$0.00	N/A
House Bill	4134	An Act to improve health care by investing in VALUE	Oppose	$0.00	N/A
Senate Bill	717	An Act to create a special commission to improve transparency and affordability at the Group Insurance Commission	Oppose	$0.00	N/A
House Bill	1168	An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth	Neutral	$0.00	N/A
Executive	Office of the Governor	Engaged in the opposition of the Governor's Health Care Bill entitled An Act to Improve Health care by investing in VALUE specifically the provisions under the section of Managing High Drug costs.	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Support	$0.00	N/A
House Bill	1148	An Act regarding Massachusetts drug price relief	Oppose	$0.00	N/A
Senate Bill	653	An Act relative to prescription drug pricing	Oppose	$0.00	N/A
Senate Bill	696	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Executive	Center for Health Information and Analysis (CHIA)	Discussions with the HPC and/or Advisory Council and CHIA with a focus on health care price variation, gross and net prescription drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO's). My interactions are with HPC Board Members (Commissioners), HPC Staff to include Executive Director, and the staff from the Center of Health Information Analysis (CHIA).	Neutral	$0.00	N/A
Senate Bill	561	An Act empowering health care consumers	Support	$0.00	N/A
Senate Bill	541	An Act relative to co-pay assistance	Support	$0.00	N/A
House Docket	3249	An Act relative to promoting transparency in the pharmaceutical industry.	Oppose	$0.00	N/A
Senate Bill	1295	An Act to reduce healthcare costs by promoting non-biased prescriber education	Oppose	$0.00	N/A
Senate Bill	712	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Oppose	$0.00	N/A
House Bill	1013	An Act relative to pharmaceutical gag clauses	Neutral	$0.00	N/A
House Bill	1099	An Act to help patients and reduce health care costs by ensuring patient adherence to medications	Support	$0.00	N/A
Senate Bill	706	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
Senate Docket	1799	An Act to ensure prescription drug cost transparency and affordability.	Oppose	$0.00	N/A
House Bill	1193	An Act providing for the establishment of a drug cost review commission	Oppose	$0.00	N/A
Senate Bill	612	An Act advancing and expanding access to telemedicine services	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Advocated for FY19 Supplemental Budget specifically Section 15, Section 226 of Chapter 139 of the acts of 2012 which stipulated an extension of the sunset of the Massachusetts patient assistance programs (drug coupons).	Support	$0.00	N/A
House Bill	926	An Act relative to consumer deductibles	Support	$0.00	N/A
Senate Bill	696	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
House Docket	771	An Act to promote transparency in prescription drug prices.	Oppose	$0.00	N/A
House Bill	1117	An Act relative to drug prices paid by carriers	Oppose	$0.00	N/A
Senate Bill	1352	An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth	Oppose	$0.00	N/A
Senate Bill	652	An Act relative to pharmaceutical "gag clauses"	Neutral	$0.00	N/A
House Bill	969	An Act empowering health care consumers	Support	$0.00	N/A
House Bill	1133	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
Senate Docket	2059	An Act to prevent transparency and prevent drug price gouging.	Oppose	$0.00	N/A
House Bill	1167	An Act relative to prescription drug price transparency	Oppose	$0.00	N/A
Senate Bill	611	An Act to promote value-based insurance design in the Commonwealth	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Promoted and assisted with information pertaining to the HPC study on the use of Prescription Drug coupons, co-pay assistance/vouchers.	Support	$0.00	N/A
House Bill	898	An Act relative to consumer deductibles	Support	$0.00	N/A
Senate Bill	1206	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
House Docket	2969	AN Act providing for the establishment of a drug cost review commission.	Oppose	$0.00	N/A
House Bill	4134	An Act to improve health care by investing in VALUE	Oppose	$0.00	N/A
Senate Bill	721	An Act relative to mandatory prescription drug coverage	Oppose	$0.00	N/A
House Bill	1177	An Act relative to protecting health care consumers	Neutral	$0.00	N/A
House Bill	915	An Act ensuring access to medications	Support	$0.00	N/A
Senate Bill	1235	An Act relative to step therapy and patient safety	Support	$0.00	N/A
House Docket	2655	An Act to promote transparency of cost controls of pharmaceutical prices.	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Oppose	$0.00	N/A
Senate Bill	1301	An Act to prevent undue influence on prescriber behavior	Oppose	$0.00	N/A
House Bill	1186	An Act strengthening HPC and CHIA market oversight	Neutral	$0.00	N/A
House Bill	1178	An Act relative to promoting transparency in the pharmaceutical industry	Support	$0.00	N/A
House Bill	1193	An Act providing for the establishment of a drug cost review commission	Oppose	$0.00	N/A
Senate Docket	1630	An Act relative to pharmaceutical price transparency and cost sharing	Oppose	$0.00	N/A
House Bill	1972	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$0.00	N/A
House Docket	2974	An Act establishing Medicare for All in MA	Neutral	$0.00	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Amendment#637; Pharmaceutical co-pay assistance. Amendment#654 to the senate budget; MassHealth supplemental rebates. Interactions with the Health Policy Commission and participation in the HPC Advisory Council to include value-based agreements with MassHealth and in the Commonwealth.	Support	$0.00	N/A
House Bill	949	An Act relative to non-medical switching	Support	$0.00	N/A
Senate Bill	712	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Oppose	$0.00	N/A
House Docket	112	An Act regarding MA drug price relief.	Oppose	$0.00	N/A
House Bill	1162	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
Senate Bill	1701	An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing	Oppose	$0.00	N/A
Senate Bill	733	An Act relative to consumer protection for prescription drug purchases	Neutral	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

Date	Recipient name	Office sought	Amount
01/13/2020	Adam Hinds	State Senator Berkshire, Hampshire, Franklin and Hampden.	$200.00
01/30/2020	James Welch	State Senator Springfield and Chicopee	$200.00
02/24/2020	Joe Boncore	State Senator First Suffolk and Middlesex	$200.00
03/09/2020	Denise Garlick	State Representative Norfolk District	$200.00
03/30/2020	Jon Santiago	State Representative 9th Suffolk	$200.00
05/05/2020	John Lawn	State Representative 10th Middlesex	$200.00
06/09/2020	Christine Barber	State Representative 34th Middlesex	$200.00
06/22/2020	Dan Ryan	State Representative 2nd Suffolk	$200.00
		Total contributions	$1,600.00

Close this page

Connect with Us